Introduction
. These interactions led to the characterization of MSP58 as a participant in transcriptional regulation. Moreover, TOJ3, an avian homologue of MSP58, was a target of the transcription factor v-Jun. Ectopic expression of TOJ3 in avian fibroblasts led to anchorage-independent growth, strongly suggesting that TOJ3 plays an important role in Jun-induced cell transformation and tumourigenesis [8] . In another study, an isoform of MSP58, p78, was found to bind to centrosomal proteins, such as Nde1 and Su48, and have an essential role in centrosome dynamics. Thus, MSP58 could be a component of the centrosomal protein complex [9] . We have shown previously that MSP58 interacts with N-myc downstream regulated gene 2 (Ndrg2), a protein intimately involved in regulation of proliferation and differentiation, and that the interaction between these two proteins is important in controlling the cell cycle of Hela cell [10] . In addition, ectopic expression of Ndrg2 inhibits glioma cell proliferation [11] . We 
have also found that MSP58 is expressed in both normal brain tissue and tumour tissue from glioma patients, but its expression is significantly up-regulated in high-grade glioblastoma tissues as well as in the four glioblastoma cell lines we examined. Based upon all these studies, we hypothesized that reducing MSP58 expression may inhibit the malignant behaviour of glioma cells. RNA interference (RNAi), a novel mechanism of post-transcriptional gene silencing, has been found in many eukaryotes. Recently, small interfering RNA (siRNA) has been shown to attenuate the expression of specific proteins both in vitro and in vivo by
sequence-specific, double-stranded RNA (dsRNA) molecules [12, 13] . Chemically synthesized small RNAs targeting the mRNA of interest could produce RNAi, but the effects were transient. The development of siRNA vectors engineered to express short hairpin RNA (shRNA) in mammalian cells has led to extensive gene-specific silencing [14] [15] [16] . In the present study, a plasmid expressing an shRNA directed against human MSP58 was generated to block the expression of MSP58 in the human glioma cell line U251. The siRNA-induced suppression of MSP58 significantly inhibited glioma tumour proliferation, invasion as well as migration.
Furthermore, we used a cDNA microarray to detect potential signal transduction pathways in which MSP58 could be involved. Our results demonstrated that MSP58 participated in multiple malignant cellular processes of human glioma cells, and suggested a potential use for highly specific RNAi-based gene-silencing therapeutics in gliomas.

Materials and methods
Tissue samples
Intracranial tissue samples were obtained from 29 [19] .
Monolayer wound-healing assay
Wound-healing assay was performed as previously described with minor modification [20, 21] 
Transwell invasion assay
The invasiveness of cells was measured by using the Matrigel invasion assay as described previously [22] . (Fig. 3C) . Here a well-characterized model for drug-induced apoptosis was used as a positive control. As shown in Fig. 3C , Cisplatin (5 g/ml, 48 hrs) induced apoptosis on 24.5% of U87 cells [19] . To explore the potential contribution of Fig. 1 mRNA expression Fig. 4A-D) . We then evaluated the effect of MSP58 suppression on anchorage-independent colony formation in soft agar as an additional assessment of tumourigenicity in vitro. (Fig. 4E and F) Fig. 5A and C, Fig. 5B and D) .
In vivo experiment
Loss of MSP58 expression abrogated anchorage-dependent and independent colony formation in U251 cells
To determine the effects of MSP58 suppression on tumourigenic processes in U251 cells, we examined the anchorage-dependent plate colony formation of U251-S and U251-Smix cells, as well as the control U251 cells. Compared with control cells, 1.6-and 1.64-fold fewer clones were observed in U251-S and U251-Smix cells, respectively (
(C) Down-regulation of MSP58 mRNA expression in clone U251-S was confirmed by semi-quantitative RT-PCR (C) and Western blot (E). (D) MSP58 was knocked down by transient transfection with the synthetic MSP58-targeting siRNA oligonucleotides. The expression of MSP58 in siRNA-treated U251 cells was confirmed by semi-quantitative RT-PCR (D) and Western blot (F). GAPDH was also amplified as an internal control for the RT-PCR, and ␤-actin
MSP58 down-regulation significantly impaired anchorage-independent colony growth, with both colony number and size much reduced. In contrast, no loss of colony-forming ability was observed in either U251-NC or U251-H1 neo cells compared with parental U251cells
. Collectively, our results indicated that inhibition of MSP58 expression impaired the colonyformation ability of U251 cells in vitro.
Effects of MSP58 suppression on migration and invasion of U251 cells
Wound healing involves a number of processes, including migration and the establishment of cell polarity. We performed a wound-healing assay to study whether siRNA-mediated inhibition of MSP58 could influence migration of U251 cells. As shown in
Since tumour cell invasion is an important feature of glioma cells, we next examined whether stable shRNA expression decreases cell invasion. The Matrigel invasion assay revealed that MSP58 depletion significantly suppressed the invasiveness of U251 cells (Fig. 5E) (Fig. 5F) 
. The number of the invaded cells declined notably in U251-S cells (P Ͻ 0.01) compared with the control groups, among which no obvious difference in invasion was observed (P Ͼ 0.05). These data demonstrate that MSP58 inhibition suppresses cell migration and invasion.
Fig. 4 MSP58 depletion suppressed both anchorage-dependent and independent colony formation. (A, B) Equal numbers of U251-S cells, Parental U251 cells and vector control U251 cells (U251-H1 neo and U251-NC) were seeded onto 60mm dish. After 14 days, the cells were fixed and stained with Giemsa (A). The average number of colonies formed in three independent experiments was quantitated (B). (C, D) Plate colony formation ability of clone U251-Smix was detected (C) and the average number of colonies formed in three independent experiment were calculated (D). (E, F) Equal numbers of U251-S cells, parental U251 cells and vector control U251 cells (U251-H1 neo and U251-NC) were plated in 0.3% soft agar and cultured for 14 days. Colony formation was photographed under microscope (E) and scored (F). Clone numbers were mean Ϯ SD of three independent experiments. *P Ͻ 0.05 versus U251, U251-H1 neo and U251-NC control cells.
Stable knockdown of MSP58 inhibited tumour growth in vivo
To test the effect of decreased MSP58 levels in glioma cells in vivo, we extended our study to evaluate the effect of MSP58 RNAi on tumour growth. Parental U251, U251-H1 neo, U251-NC and U251-S cells were injected into nude mice (Fig. 6A) . Figure 6B showed the time course of the growth of tumours initiated by different U251 transfectants. By day 24, mice injected with U251-S cells showed a statistically significant decrease in average tumour size compared with all other groups (Fig. 6C) . The tumour of each mouse was removed on day 24 and weighed. MSP58 RNAi significantly decreased the solid tumour mass compared with the control groups (Fig. 6D ). These data demonstrate that inhibition of MSP58 expression suppresses tumour formation in vivo. used proliferation marker. As shown in Fig. 6E (Fig. 1) . In the present study, we examined the role of MSP58 in cellular proliferation inhibition and other cellular malignant progression of glioma cells by depleting of MSP58 with a specific RNAi in U251 cells (Fig. 2) . We demonstrated that depletion of MSP58 inhibited the U251 glioma cell proliferation. cDNA array analysis was also performed to try to explain the molecular mechanism under its effect on cell proliferation inhibition.
Fig. 5 MSP58 suppression modulated migration and invasion in U251 cells. (A) Effect of MSP58 depletion on cell migration. Monolayer of U251, U251-H1 neo, U251-NC and U251-S cells were mechanically wounded with a pipette tip. Repair of the lesion by cell migration was photographed 24 h later. (B) Quantification of cell migration. The distance of cell migration was calculated as described in "Materials and Methods". Data were obtained from three independent experiments and presented as mean Ϯ SD. (C) Representative photographs of wound-healing assay at time 0 and 24 hours in U251-NC and U251-Smix cells. (D) Quantification of U251-Smix cell migration compared to U251-NC. (E) MSP58 shRNA diminished cell invasion of U251 cells. Each of the indicated U251 cell types was assayed for cell invasion using transwell tissue culture dishes (8 µm pore size). (F) The average cell counts of invading cells from 6 high power fields (HPFs
We found that specifically reducing MSP58 by RNAi negatively affected tumour cell growth in vitro (Fig. 3A) . The reduced growth was the result of inhibited proliferation, not apoptosis (Fig. 3C) . Because this effect could be due to long-term changes in gene expression, we also examined apoptosis in U251 cells transiently transfected with a synthetic siRNA and got the same result (Fig. 3D) . These results are consistent with a previous study that overexpression of p78, an isoform of MSP58, increased cell growth and the rate of proliferation, whereas disruption of p78 function delayed entrance into mitotic prometaphase [9] . As [29, 30] . In accordance with these observations, we found down-regulation of some proliferation-related genes, such as E2F2 and Ki67, which are used as proliferation markers in a variety of tumour types [31] [32] [33] [34] [35] . Some cell cycle-related genes, including ATM, ATR, were also increased by MSP58 shRNA treatment, all of which are known to either arrest the cell cycle or inhibit the growth of different cancer cells [36, 37] . Moreover, increased expression of ANAPC2, which is responsible for the G2/M transition [38] (Fig. 5) . Cell invasion is the result of degradation of extracellular matrix (ECM) proteins by specific proteases. More than one study has reported that the matrix metalloproteinase (MMP) family is activated to promote tumour cell invasion and angiogenesis [39, 40] .
Further studies are needed to determine the molecular mechanism where MSP58 shRNA suppresses U251 cell invasiveness.
Our results also showed that suppression of MSP58 affected the transformed morphology of the glioma cells. The inhibition of anchorage-dependent and -independent growth were observed clearly in U251-S cells compared with the control cells, which suggests that depletion of MSP58 could enhance mitogenic or survival signals (Fig. 4) 
